Xetra
10.04.26 | 17:35
4,530 Euro
+0,09 % +0,004
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,504 | 4,580 | 10.04. | |
| 4,500 | 4,574 | 10.04. |
► 10.04.: | | | | | | | | |
► 09.04.: 09:00 | 10:00 | 11:00 | 12:00 | 12:55 | | | | |
► Aktueller EVOTEC Börsenkurs + Xetra-Orderbuch
► 09.04.: 09:00 | 10:00 | 11:00 | 12:00 | 12:55 | | | | |
► Aktueller EVOTEC Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 5,270 | 1.000 | |||
| 5,260 | 1.000 | |||
| 5,050 | 1.400 | |||
| 4,970 | 270 | |||
| 4,950 | 900 | |||
| 4,900 | 1.000 | |||
| 4,740 | 500 | |||
| 4,650 | 285 | |||
| 4,550 | 1.777 | |||
| 4,538 | 7.088 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/evt.htm [/URL] | ||||
| 2.000 | 4,480 | |||
| 1.777 | 4,474 | |||
| 393 | 4,450 | |||
| 1.211 | 4,440 | |||
| 750 | 4,420 | |||
| 1.200 | 4,410 | |||
| 600 | 4,400 | |||
| 7.428 | 4,380 | |||
| 1.000 | 4,350 | |||
| 200 | 4,300 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 16.559 | 0,919 | 15.220 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:29:45 | 4,498 | 224 |
| 17:29:45 | 4,498 | 46 |
| 17:29:45 | 4,496 | 229 |
| 17:29:28 | 4,492 | 646 |
| 17:29:28 | 4,498 | 238 |
| 17:29:28 | 4,496 | 22 |
| 17:29:11 | 4,494 | 252 |
| 17:28:34 | 4,490 | 230 |
| 17:27:41 | 4,494 | 5 |
| 17:27:30 | 4,486 | 1 |
| 17:27:25 | 4,486 | 100 |
| 17:27:09 | 4,490 | 21 |
| 17:26:29 | 4,490 | 238 |
| 17:24:42 | 4,494 | 299 |
| 17:24:22 | 4,490 | 324 |
| 17:24:13 | 4,488 | 58 |
| 17:24:03 | 4,488 | 257 |
| 17:23:41 | 4,488 | 227 |
| 17:23:38 | 4,488 | 73 |
| 17:23:38 | 4,488 | 612 |
| Tagesumsatz Xetra | +0,004 +0,09 % | 811.149 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | EVOTEC SE am Abend: Spannung trotz kleinem Rücksetzer! | 47 | Maximilian Berger | ||
| Fr | Evotec zieht durch: Warum erfahrene Anleger vor dem Wochenende zugreifen - Meine klare Einschätzung dazu | Hebelschein-Spekulant | |||
| Fr | Unlocking Massive Potential in Pharma's Largest Segment: Innovator Vidac Pharma, Industry Leader Bayer, or Turnaround Candidate Evotec? | 97 | The Market Herald Canada | ||
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 465 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| EVOTEC Aktie jetzt für 0€ handeln | |||||
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 445 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen |
1 2 3 4 5 Weiter >>
875 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Fr | MetaVia Inc.: MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity | PR Newswire | 16-Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults
CAMBRIDGE, Mass., April 10, 2026... ► Artikel lesen | |
| Fr | eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast | ACCESS Newswire | LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals... ► Artikel lesen | |
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.04.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 10.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.04.2026.ISIN NameAU000000ICI5... ► Artikel lesen | |
| Fr | Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics | AFX News | THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations... ► Artikel lesen | |
| Fr | Sharp Therapeutics Corp.: Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering | Newsfile | Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EVOTEC SE finden Sie auf Wallstreet Online.